A Model for Gene Therapy
Gene Replacement in the Treatment of Sickle Cell Anemia and Thalassemia
-
- $5.99
-
- $5.99
Publisher Description
This research paper was written in
1978 by Ward Merkeley, M.D. when
he was a first year medical student
attending the University Of Utah
School of Medicine. It is one of the
first original papers suggesting and
exploring the theoretical potentials
and practical limitations of Gene
Therapy. The paper discusses in
technical detail the means of isolating
and inserting a normal hemogloblin
gene into the erythoid stem cells of
people with Sickle Cell Anemia and B
Thalassemia. The difficulties and
limitation of Gene Therapy are
discussed in detail, as well as, some
ethical considerations.
Change We Can Believe in: "Race" and Continuing Selection in the Human Genome.
2009
Understanding Preventing and Eliminating Cancer
2013
The Drug Pipeline; Abbott Striving for an Edge in the Race to Develop New Medicines (Business)
2008
Stem Cells, Creams and Aging ... with Science Lagging (Daily Break)
2008
Theory on Jewish Iqs Raises Brows, Sparks Ire (N)
2009
The School of Pharmacy at Queen's University Belfast - Research Prospectus
2015